Compare CVS Health Corp (CVS) vs Nano Dimension Ltd - ADR (NNDM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Nano Dimension Ltd - ADR — how do they compare? CVS Health Corp trades at $93.58 (market cap $119.58B), while Nano Dimension Ltd - ADR trades at $1.67 (market cap $350.49M). The key difference: CVS Health Corp is far larger — about 341.2× Nano Dimension Ltd - ADR's market cap, and CVS Health Corp pays a 2.84% dividend while Nano Dimension Ltd - ADR pays none. Which is the better fit depends on your goals.
| CVS | NNDM | |
|---|---|---|
Market Cap | $119.58B | $350.49M |
Sector | Health | Technology |
52-Week High | $110.60 | $2.14 |
52-Week Low | $65.51 | $1.21 |
Enterprise Value | $181.93B | -$54.35M |
Dividend Yield | 2.84% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.67, down slightly by 0.03% today. The stock shows strong fundamental momentum with recent quarterly earnings beats, including Q2 2026 EPS of $2.58 versus $1.87 expected, and raised 2026 guidance. Valuation metrics appear reasonable with a P/E of 24.67 and P/S of 0.29. Technical indicators are mixed with a bullish overall signal but bearish moving averages, with key support at $95 and resistance at $96.
The outlook for CVS is positive, supported by earnings strength and analyst consensus, but risks include margin pressure and rising debt levels. The consensus price target of $115.90 implies significant upside, though investors should monitor execution on guidance and healthcare regulatory changes.
Nano Dimension (NNDM) trades at $1.63, showing no change recently. The stock exhibits a bullish technical signal with strong moving average support, though RSI levels suggest overbought conditions. Fundamentally, the company reported revenue growth to $102.44M in 2025 but posted a significant net loss of $293.30M, reflecting ongoing profitability challenges. Recent strategic actions include cost-saving initiatives and the planned sale of MarkForged to Stratasys, aimed at reducing cash burn.
The outlook remains speculative due to persistent losses and cash flow concerns, despite potential from strategic divestitures. Investment opportunities hinge on successful execution of cost reductions and future profitability. Key risks include high cash burn, competitive pressures, and execution uncertainty amid leadership changes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Nano Dimension Ltd - ADR
Nano Dimension Ltd is engaged in research and development of a three-dimensional printer that prints electronic circuit boards, also known as printed circuit boards, and ink materials and products based on nanotechnology. Its products consist of two main product lines - Dragonfly 2020 3D printer and proprietary ink products. The company's Dragonfly 2020 3D printer currently in development uses proprietary ink and integrated software to quickly create fully functioning PCB prototypes. Geographically, it generates maximum revenue from the USA followed by the Asia Pacific and Europe and Israel. It serves the Commercial, Research and Printing services industries.
Read more on NNDM →
